Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

Hepatocyte growth factor (HGF) is associated with subclinical and clinical atherosclerosis. However, the significance of change in HGF and development of atherosclerotic disease is unknown. In a large and diverse population-based cohort, we report that change in the biomarker HGF is an independent p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am Heart J
Autors principals: Decker, Paul A., Larson, Nicholas B., Bell, Elizabeth J., Pankow, James S., Hanson, Naomi Q., Wassel, Christina L., Tsai, Michael Y., Bielinski, Suzette J.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581609/
https://ncbi.nlm.nih.gov/pubmed/31085382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2019.03.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars